Global Checkpoint Inhibitors for Treating Cancer Market Status and Outlook 2018-2025

July 2018 | 155 pages | ID: G6BC8F854C6EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Bristol-Myers Squibb(BMS)
• Merck
• Roche

Market by Type

• PD-1 inhibitors
• PD-L1 inhibitors
• CTLA-4 inhibitors

Market by Application

• Melanoma treatment
• Bladder cancer treatment
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Checkpoint Inhibitors for Treating Cancer Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 PD-1 inhibitors
  3.1.2 PD-L1 inhibitors
  3.1.3 CTLA-4 inhibitors
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Melanoma treatment
  4.1.2 Bladder cancer treatment
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 PD-1 inhibitors Production by Region
    6.1.1.2 PD-L1 inhibitors Production by Region
    6.1.1.3 CTLA-4 inhibitors Production by Region
  6.1.2 Production by Application
    6.1.2.1 Melanoma treatment Production by Region
    6.1.2.2 Bladder cancer treatment Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 PD-1 inhibitors Demand by Region
    6.2.1.2 PD-L1 inhibitors Demand by Region
    6.2.1.3 CTLA-4 inhibitors Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Melanoma treatment Demand by Region
    6.2.2.2 Bladder cancer treatment Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Bristol-Myers Squibb(BMS)
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Merck
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Roche
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Checkpoint Inhibitors for Treating Cancer Industry Dynamics & Regulations List
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue, Cost and Margin, 2015-2018E
Table Global Checkpoint Inhibitors for Treating Cancer Market Status by Type 2015-2018E, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Status by Application 2015-2018E, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Status by Application 2015-2018E, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market by Region 2015-2018E, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Region in 2018, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market by Region 2015-2018E, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Region in 2018, in Volume
Table PD-1 inhibitors Production Value by Region 2015-2018E, in USD Million
Table PD-1 inhibitors Production Volume by Region 2015-2018E, in Volume
Table PD-L1 inhibitors Production Value by Region 2015-2018E, in USD Million
Table PD-L1 inhibitors Production Volume by Region 2015-2018E, in Volume
Table CTLA-4 inhibitors Production Value by Region 2015-2018E, in USD Million
Table CTLA-4 inhibitors Production Volume by Region 2015-2018E, in Volume
Table Melanoma treatment Production Value by Region 2015-2018E, in USD Million
Table Melanoma treatment Production Volume by Region 2015-2018E, in Volume
Table Bladder cancer treatment Production Value by Region 2015-2018E, in USD Million
Table Bladder cancer treatment Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table PD-1 inhibitors Market Size by Region 2015-2018E, in USD Million
Table PD-1 inhibitors Market Size by Region 2015-2018E, in Volume
Table PD-L1 inhibitors Market Size by Region 2015-2018E, in USD Million
Table PD-L1 inhibitors Market Size by Region 2015-2018E, in Volume
Table CTLA-4 inhibitors Market Size by Region 2015-2018E, in USD Million
Table CTLA-4 inhibitors Market Size by Region 2015-2018E, in Volume
Table Melanoma treatment Market Size by Region 2015-2018E, in USD Million
Table Melanoma treatment Market Size by Region 2015-2018E, in Volume
Table Bladder cancer treatment Market Size by Region 2015-2018E, in USD Million
Table Bladder cancer treatment Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalCheckpoint Inhibitors for Treating Cancer Forecast by Type 2019F-2025F, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Forecast by Type 2019F-2025F, in Volume
Table Checkpoint Inhibitors for Treating Cancer Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Checkpoint Inhibitors for Treating Cancer Market Forecast by Region 2019F-2025F, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Market Forecast by Region 2019F-2025F, in Volume
Table Bristol-Myers Squibb(BMS) Information
Table Checkpoint Inhibitors for Treating Cancer Sales, Cost, Margin of Bristol-Myers Squibb(BMS)
Table Merck Information
Table Checkpoint Inhibitors for Treating Cancer Sales, Cost, Margin of Merck
Table Roche Information
Table Checkpoint Inhibitors for Treating Cancer Sales, Cost, Margin of Roche
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue by Company 2015-2017, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume by Company 2015-2017, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Checkpoint Inhibitors for Treating Cancer Picture
Figure Checkpoint Inhibitors for Treating Cancer Industry Chain Diagram
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Revenue 2015-2018E, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume 2015-2018E, in Volume
Figure Global Checkpoint Inhibitors for Treating Cancer Market Status by Type 2015-2018E, in Volume
Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2018E, in USD Million
Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2018E, in Volume
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2018E, in USD Million
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2018E, in Volume
Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2018E, in USD Million
Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2018E, in Volume
Figure Middle East Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2018E, in Volume
Figure Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2018E, in USD Million
Figure Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2015-2018E, in Volume
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Price Forecast 2019F-2025F
Figure Global Checkpoint Inhibitors for Treating Cancer Gross Margin Forecast 2019F-2025F
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Revenue by Company in 2018, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Price by Company in 2018
Figure Global Checkpoint Inhibitors for Treating Cancer Gross Margin by Company in 2018